Inhibition of HSP90 activity by small-molecule inhibitors has been demonstrated to cause potent reversal of diseases in the model of cancer, neurodegenerative disorders, epilepsy, infections and inflammatory diseases 2. The gene discussed is HSP90AB1; the disease is cancer.